Quanterix

Quanterix is a company that digitizes biomarker analysis with the aim of advancing precision health sciences. The company’s ultra-sensitive detection solution, Simoa, has the potential to transform today’s healthcare delivery by enabling researchers to closely examine the role of biomarkers across the disease continuum. Quanterix’s technology is designed to enable earlier disease detection, better prognoses, and more precise treatment options, improving the quality of life and longevity for future generations. The technology is currently used in research applications across multiple therapeutic areas, including oncology, neurology, cardiology, inflammation, and infectious diseases. Founded in 2007 and headquartered in Billerica, Massachusetts, Quanterix is committed to sustainably delivering high-quality, innovative biomarker measurement products and testing services to meet customer needs and regulatory requirements.